• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EDWARDS LIFESCIENCES COMMANDER DELIVERY SYSTEM; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EDWARDS LIFESCIENCES COMMANDER DELIVERY SYSTEM; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED Back to Search Results
Model Number 9750CM29A
Device Problems Difficult to Remove (1528); Material Separation (1562); Material Deformation (2976)
Patient Problem Insufficient Information (4580)
Event Date 10/16/2023
Event Type  Injury  
Manufacturer Narrative
The investigation is ongoing.
 
Event Description
During a tavr procedure using a 29mm sapien 3 resilia valve via transfemoral approach, the balloon ruptured on inflation during deployment.The team pulled the ruptured balloon into the sheath.A decision was made to remove both the sheath and delivery as a unit.Upon removal, resistance was evident at the access site.The team could not remove the sheath and delivery system.At this point, the team wired from contralateral access site and used a 12.0mm balloon to occlude flow.A vascular surgeon proceeded with a cut down to remove the balloon and sheath.The common femoral artery was patched, and the patient is stable.The valve was deployed and fully functioning.The device will be returned for examination.
 
Manufacturer Narrative
The events reported are anticipated in the risk management documentation for transcatheter heart valve procedures.A previous investigation into this type of event is captured in an edwards lifesciences technical summary and applies to this complaint.Additional assessment of the failure mode is not required at this time.The 29mm commander delivery system (ds) was returned for examination and confirmed the reported events.A visual examination found that the balloon burst radially with no missing balloon pieces observed, the distal portion of the distal balloon wing material was stretched, and the burst inflation balloon was caught at the distal end of the sheath.Dimensional testing indicated that all measurements taken of the balloon's single wall thickness met specifications.3mensio imagery provided showed that there was calcification present in the landing zone and that the patient had tortuous and calcified iliac vessels.Per the technical summary, the ifu, current risk mitigations include design and manufacturing controls, and training manuals have been reviewed, no inadequacies have been identified with regards to warnings, contraindications, and the directions/conditions for the successful use of the device.The complaint of a balloon burst was confirmed based on an evaluation of the returned device.Available information suggests that patient factors (calcification) likely contributed to the event.Per the event description and as observed in the provided imagery, the patient had a "moderate/severe" degree of calcification present in the landing zone.The presence of calcification can create a challenging anatomy for balloon inflation.While the balloons are sufficiently designed and tested to ensure the burst pressure is at or above the rated burst pressure, calcified nodules can compromise the structure of the balloon wall via the following mechanisms such as puncture, local overstretching, open cell impingement, or stress concentration.The complaint of withdrawal difficulties was confirmed based on the evaluation of the returned device.Available information suggests procedural factors (withdrawal of burst balloon) likely contributed to the event.As the balloon burst, the altered balloon profile could have made it more susceptible to catching on the distal end of the sheath tip, which would have then led to the experienced retrieval difficulty.Complaint histories for all reported events are reviewed against trending control limits on a monthly basis, and any excursions above the control limits are assessed and documented as part of this monthly review.Since no edwards product defects or labeling deficiencies were identified, no corrective or preventative action is required.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
COMMANDER DELIVERY SYSTEM
Type of Device
AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED
Manufacturer (Section D)
EDWARDS LIFESCIENCES
1 edwards way
irvine CA 92614
Manufacturer (Section G)
EDWARDS LIFESCIENCES
1 edwards way
irvine CA 92614
Manufacturer Contact
renee van dorne
1 edwards way
irvine, CA 92614
9492506385
MDR Report Key18089042
MDR Text Key327586136
Report Number2015691-2023-17315
Device Sequence Number1
Product Code NPT
UDI-Device Identifier00690103217001
UDI-Public(01)00690103217001(17)250605(10)65116964
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P140031
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,User Facility,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 01/24/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number9750CM29A
Device Lot Number65116964
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 10/16/2023
Initial Date FDA Received11/07/2023
Supplement Dates Manufacturer Received01/19/2024
Supplement Dates FDA Received01/24/2024
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured06/06/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age89 YR
Patient SexMale
-
-